LGALS3BP and early-onset autosomal dominant Alzheimer disease: First, proteomics screening and statistical analysis show that blood biomarkers LGALS3BP, ACE, and POSTN effectively screen for cerebral amyloid depositions and clinically diagnose Alzheimer’s disease, but the theoretical basis is still lacking.